ARVELLE THERAPEUTICS B.V. group: subsidiaries and structure
besloten vennootschap met beperkte aansprakelijkheid (BV) · AMSTERDAM, Netherlands · LEI 549300B58TL8Q7ZKK249
2subsidiaries
2countries
0held directly
2lapsed LEIs
2links on accounts older than 24 months
0ISINs of subsidiaries
Summary
ARVELLE THERAPEUTICS B.V. is the ultimate parent of 2 subsidiaries with LEIs in 2 countries, as reported to GLEIF. 0 are held directly; the others sit below intermediate companies. The largest numbers are in Switzerland (1) and in the United States (1). 2 of the subsidiaries have a lapsed LEI, and 2 links rest on accounts older than 24 months.
Written from GLEIF data using fixed, reviewed sentence templates.
Subsidiaries by country
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 24 Jul 2021 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
2 subsidiaries have data-quality notes; they are listed on each company page.
Group structure
Indentation shows the direct parent reported to GLEIF.
Subsidiaries
| Company | Country | City | LEI | Accounts year | Notes |
|---|---|---|---|---|---|
| ARVELLE THERAPEUTICS INTERNATIONAL GMBH | Switzerland | ZUG | 549300WF406Q60XG8M06 | 2019 | lapsed > 24 months |
| ARVELLE THERAPEUTICS INC. | United States | WILMINGTON | 549300NSUBNKICK27E45 | 2019 | lapsed > 24 months |